0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
Lupin records an S&P Global ESG score of 91 for 2025, rising from 17 in 2021 and moving ahead of the pharma industry average while strengthening its ESG initiatives.
Share this article
If you liked this article share it with your friends.they will thank you later